1
|
Cummins J, Lienert F, Su A, Melander E, West RL, Salgado F. Understanding the journey towards rabies vaccination for travellers: Results of a cross-sectional survey with patients and providers in the US, Germany, Sweden, and Switzerland. Travel Med Infect Dis 2024; 62:102767. [PMID: 39368795 DOI: 10.1016/j.tmaid.2024.102767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 07/31/2024] [Accepted: 10/02/2024] [Indexed: 10/07/2024]
Abstract
BACKGROUND Although cases of rabies in international travellers are uncommon, they are a fatal risk which can be alleviated through vaccination prior to travel. As international travel recovers post-COVID, it is vital that travellers are made aware of the risk of rabies when travelling to endemic countries and supported to receive the vaccine when eligible. METHODS Online surveys were conducted in the US, Germany, Sweden and Switzerland between November 2022-January 2023 with both patients and healthcare providers (HCPs). Eligibility criteria for patients included those eligible for rabies pre-exposure prophylaxis (PrEP) due to travel location and activity; HCPs had to be providers of travel vaccinations. In both surveys, questions were asked about discussion of rabies vaccination, decision of whether to administer a rabies vaccine, recommendation to get the rabies vaccine, and final decision to get a vaccine. RESULTS The final patient sample included n = 1557 patients who were eligible for rabies pre-exposure prophylaxis (US n = 504, Germany n = 353, Sweden n = 350, Switzerland n = 350) and n = 219 HCPs (US n = 75, Germany n = 75, Sweden n = 32, Switzerland n = 37). Although all patients in the sample were eligible for rabies vaccination, only 15 % felt they were at risk of getting rabies, and only 18 % received the rabies vaccine before their trip. HCPs reported discussing PrEP and/or PrEP and PEP with 30 % of patients presenting for travel vaccination advice, on average. CONCLUSIONS Awareness and perception of rabies risk, and lack of consistent HCP discussion of the need for rabies PrEP may be major barriers to uptake of the vaccine for patients who are eligible to receive it.
Collapse
Affiliation(s)
| | | | - Annabel Su
- Ipsos, 3 Thomas More Square, E1W 1YW, London, United Kingdom
| | - Elaine Melander
- Ipsos, 3 Thomas More Square, E1W 1YW, London, United Kingdom
| | - Rebecca L West
- Ipsos, 3 Thomas More Square, E1W 1YW, London, United Kingdom
| | | |
Collapse
|
2
|
Overduin LA, Koopman JPR, Prins C, Verbeek-Menken PH, de Pijper CA, Heerink F, van Genderen PJJ, Grobusch MP, Visser LG. Rabies knowledge gaps and risk behaviour in Dutch travellers: An observational cohort study. Travel Med Infect Dis 2024; 60:102739. [PMID: 39009201 DOI: 10.1016/j.tmaid.2024.102739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Revised: 05/06/2024] [Accepted: 06/24/2024] [Indexed: 07/17/2024]
Abstract
BACKGROUND Travellers visiting rabies-endemic countries are at risk of rabies infection. Assessing travellers' knowledge and risk perception of rabies and risk behaviour during travel can help identify knowledge gaps and improve pre-travel risk education. METHODS Cohort study in Dutch adult travellers, using two surveys: one before travel to assess knowledge and perception of rabies, and one after return to identify risk behaviour during travel. RESULTS The pre-travel and post-travel survey were completed by 301 and 276 participants, respectively. 222 participants had travelled to a high-risk rabies-endemic country. 21.6 % of the participants scored their rabies knowledge as poor. Some participants were unaware cats or bats can transmit rabies (26.6 % and 13.6 %, respectively), or that post-exposure prophylaxis (PEP) is required for certain exposures such as skin abrasions without bleeding or licks on damaged skin (35.5 % and 18.9 %, respectively), while 27.9 % of participants did not know PEP needs to be administered within one day. 115 participants (51.8 %) reported any form of contact with any animal during travel. Two participants reported animal exposure, of which one took adequate PEP measures. Risk factors for animal contact abroad were regularly touching cats or dogs at home or abroad, longer travel duration, having pets during childhood and being an animal lover. CONCLUSIONS Pre-travel rabies risk education currently does not meet travellers' needs, which is reflected in knowledge gaps and engagement in risk behaviour during travel. During pre-travel health advice, avoiding animal contact abroad should be emphasized, and additional education is required about indications for PEP.
Collapse
Affiliation(s)
- Lisanne A Overduin
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands.
| | - Jan Pieter R Koopman
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands
| | - Corine Prins
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands
| | - Petra H Verbeek-Menken
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands
| | - Cornelis A de Pijper
- Centre for Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Fiona Heerink
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands
| | | | - Martin P Grobusch
- Centre for Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Leo G Visser
- Leiden University Center for Infectious Diseases, Leiden University Medical Centre, Leiden, the Netherlands
| |
Collapse
|
3
|
Bonilla-Aldana DK, Ruiz-Saenz J, Martinez-Gutierrez M, Villamil-Gomez W, Mantilla-Meluk H, Arrieta G, León-Figueroa DA, Benites-Zapata V, Barboza JJ, Muñoz-Del-Carpio-Toia A, Franco OH, Cabrera M, Sah R, Al-Tawfiq JA, Memish ZA, Amer FA, Suárez JA, Henao-Martinez AF, Franco-Paredes C, Zumla A, Rodriguez-Morales AJ. Zero by 2030 and OneHealth: The multidisciplinary challenges of rabies control and elimination. Travel Med Infect Dis 2023; 51:102509. [PMID: 36435448 DOI: 10.1016/j.tmaid.2022.102509] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2022] [Accepted: 11/21/2022] [Indexed: 11/24/2022]
Affiliation(s)
- D Katterine Bonilla-Aldana
- Research Unit, Universidad Continental, Huancayo, Peru; Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología (ACIN), Bogotá, DC, Colombia
| | - Julian Ruiz-Saenz
- Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología (ACIN), Bogotá, DC, Colombia; Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Bucaramanga, Colombia
| | - Marlen Martinez-Gutierrez
- Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología (ACIN), Bogotá, DC, Colombia; Grupo de Investigación en Microbiología Veterinaria, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia
| | - Wilmer Villamil-Gomez
- Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología (ACIN), Bogotá, DC, Colombia; Secretaría de Salud de Barranquilla, Barranquilla, Atlántico, Colombia
| | - Hugo Mantilla-Meluk
- Colección de Mastozoología y Centro de Estudios de Alta Montaña, Universidad del Quindío, Carrera 15 Calle 12N, Armenia, Quindío, Colombia
| | - German Arrieta
- Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología ACIN, Bogotá, DC, Colombia; Universidad de Córdoba, Instituto de Investigaciones Biológicas del Trópico, Clínica Salud Social Sincelejo, Corporación Universitaria del Caribe: CECAR, Sucre, Colombia
| | - Darwin A León-Figueroa
- Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo, Peru; Unidad de Revisiones Sistemáticas y Meta-Análisis, Tau-Relaped Group, Trujillo, Peru
| | - Vicente Benites-Zapata
- Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru
| | - Joshuan J Barboza
- Vicerrectorado de Investigación, Universidad Norbert Wiener, Lima, Peru
| | | | - Oscar H Franco
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Maritza Cabrera
- Centro de Investigación de Estudios Avanzados del Maule CIEAM, Universidad Católica del Maule, Talca, 3480094, Chile; Facultad Ciencias de la Salud, Universidad Católica del Maule, Talca, 3480094, Chile
| | - Ranjit Sah
- Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; Research Scholar, Harvard Medical School, Boston, MA, USA; Dr. D.Y Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India
| | - Jaffar A Al-Tawfiq
- Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Diseases Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Diseases Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Ziad A Memish
- Al-Faisal University, Riyadh, Saudi Arabia; King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - Fatma A Amer
- Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig, Egypt; Chair of Viral Infection Working Group, and Executive Committee Member, International Society for Antimicrobial Chemotherapy VIWG/ISAC, Egypt
| | - José Antonio Suárez
- Instituto Conmemorativo Gorgas de Estudios de la Salud, Investigator 1 of the SNI, Senacyt, Panama City, Panama
| | - Andres F Henao-Martinez
- Division of Infectious Diseases, School of Medicine, University of Colorado Anschutz Medical Campus, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO, 80045, USA
| | - Carlos Franco-Paredes
- Hospital Infantil de México, Federico Gómez, México City, Mexico; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
| | - Alimuddin Zumla
- Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK
| | - Alfonso J Rodriguez-Morales
- Committee of Tropical Medicine, Zoonoses and Travel Medicine, Asociación Colombiana de Infectología ACIN, Bogotá, DC, Colombia; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon; Master of Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, 4861, Peru; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas - Institución Universitaria Visión de las Américas, 660003, Pereira, Risaralda, Colombia; Editor-in-Chief, Travel Medicine and Infectious Diseases.
| |
Collapse
|
5
|
Vlot JA, van Steenbergen JE. Hospital-based care and/or death followed by repatriation in Dutch travelers: The HAZARD study. Travel Med Infect Dis 2022; 49:102329. [PMID: 35460875 DOI: 10.1016/j.tmaid.2022.102329] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 10/18/2022]
Abstract
BACKGROUND Travelers can experience health problems while abroad. This descriptive study aimed to quantify the disease burden leading to hospital-based care, repatriation or death in Dutch travelers during a stay in a foreign country, including Europe. METHODS Retrospective study of demographic and clinical data from three medical assistance centers (MACs) and the Dutch Ministry of Foreign Affairs on Dutch travelers receiving hospital-based care or who died abroad in the years 2010-2014. Diagnoses were coded according to the International Classification of Diseases (ICD) and classified using the Global Burden of Disease tool. RESULTS Data was available for 77,741 travelers' incidents: 75,385 medical consultations and 2356 deaths. Four in five travelers received inpatient care, of which 36% concerned older travelers (65+) who had significantly longer hospital stays. Overall the top three diagnoses were: injuries (29%), infectious diseases (17%), and cardiovascular diseases (17%). Mental illness was reported in nearly 1.5% of the travelers. Incidence proportions were highest in South-Eastern Asia, with enteric infections as most common diagnosis. Injuries and communicable diseases occurred most often in South-Eastern Asia, while non-communicable diseases were mostly reported in South America. One in five travelers who consulted a physician was repatriated back home, mostly on a scheduled flight with or without medical escort. Cardiovascular diseases and injuries were the leading causes of death. CONCLUSIONS Not only communicable diseases, but also injuries and chronic diseases (in particular cardiovascular diseases) frequently affected travelers' health while staying abroad and frequently necessitated hospital-based care. This should be addressed during the pre-travel counseling.
Collapse
Affiliation(s)
- Jessica A Vlot
- Department of Infectious Diseases, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
| | - Jim E van Steenbergen
- Department of Infectious Diseases, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA, Leiden, the Netherlands; Center for Infectious Disease Control, Netherlands Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands
| | | |
Collapse
|
6
|
Graumans W, Stone WJR, Bousema T. No time to die: An in-depth analysis of James Bond's exposure to infectious agents. Travel Med Infect Dis 2021; 44:102175. [PMID: 34662727 DOI: 10.1016/j.tmaid.2021.102175] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Revised: 10/08/2021] [Accepted: 10/12/2021] [Indexed: 01/29/2023]
Abstract
Global travelers, whether tourists or secret agents, are exposed to a smörgåsbord of infectious agents. We hypothesized that agents pre-occupied with espionage and counterterrorism may, at their peril, fail to correctly prioritize travel medicine. To examine our hypothesis, we examined adherence to international travel advice during the 86 international journeys that James Bond was observed to undertake in feature films spanning 1962-2021. Scrutinizing these missions involved ∼3113 min of evening hours per author that could easily have been spent on more pressing societal issues. We uncovered above-average sexual activity, often without sufficient time for an exchange of sexual history, with a remarkably high mortality among Bond's sexual partners (27.1; 95% confidence interval 16.4-40.3). Given how inopportune a bout of diarrhea would be in the midst of world-saving action, it is striking that Bond is seen washing his hands on only two occasions, despite numerous exposures to foodborne pathogens. We hypothesize that his foolhardy courage, sometimes purposefully eliciting life-threatening situations, might even be a consequence of Toxoplasmosis. Bond's approach to vector-borne diseases and neglected tropical diseases is erratic, sometimes following travel advice to the letter, but more often dwelling on the side of complete ignorance. Given the limited time Bond receives to prepare for missions, we urgently ask his employer MI6 to take its responsibility seriously. We only live once.
Collapse
Affiliation(s)
- Wouter Graumans
- Department of Medical Microbiology & Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - William J R Stone
- Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Teun Bousema
- Department of Medical Microbiology & Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
| |
Collapse
|